Cargando…
O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer
Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whethe...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052337/ https://www.ncbi.nlm.nih.gov/pubmed/33863873 http://dx.doi.org/10.1038/s41420-021-00468-2 |
_version_ | 1783679899128561664 |
---|---|
author | Zhu, Guoqing Murshed, Abduh Li, Haojie Ma, Ji Zhen, Ni Ding, Miao Zhu, Jiabei Mao, Siwei Tang, Xiaochen Liu, Li Sun, Fenyong Jin, Lei Pan, Qiuhui |
author_facet | Zhu, Guoqing Murshed, Abduh Li, Haojie Ma, Ji Zhen, Ni Ding, Miao Zhu, Jiabei Mao, Siwei Tang, Xiaochen Liu, Li Sun, Fenyong Jin, Lei Pan, Qiuhui |
author_sort | Zhu, Guoqing |
collection | PubMed |
description | Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whether O-GlcNAcylation can increase the sensitivity of hepatocellular carcinoma (HCC) cells to ferroptosis remains unknown. In the present study, we found that O-GlcNAcylation increased the sensitivity of HCC cells to ferroptosis via YAP. Moreover, YAP increased the iron concentration in HCC cells through transcriptional elevation of TFRC via its O-GlcNAcylation. With YAP knockdown or YAP-T241 mutation, the increased sensitivity to ferroptosis induced by O-GlcNAcylation was abolished. In addition, the xenograft assay confirmed that O-GlcNAcylation increased ferroptosis sensitivity via TFRC in vivo. In summary, we are the first to find that O-GlcNAcylation can increase ferroptosis sensitivity in HCC cells via YAP/TFRC. Our work will provide a new basis for clinical therapeutic strategies for HCC patients. |
format | Online Article Text |
id | pubmed-8052337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80523372021-05-05 O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer Zhu, Guoqing Murshed, Abduh Li, Haojie Ma, Ji Zhen, Ni Ding, Miao Zhu, Jiabei Mao, Siwei Tang, Xiaochen Liu, Li Sun, Fenyong Jin, Lei Pan, Qiuhui Cell Death Discov Article Ferroptosis is a form of regulated cell death characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. YAP has been reported to play a pivotal role in controlling ferroptotic death, and the expression of YAP is enhanced and stabilized by O-GlcNAcylation. However, whether O-GlcNAcylation can increase the sensitivity of hepatocellular carcinoma (HCC) cells to ferroptosis remains unknown. In the present study, we found that O-GlcNAcylation increased the sensitivity of HCC cells to ferroptosis via YAP. Moreover, YAP increased the iron concentration in HCC cells through transcriptional elevation of TFRC via its O-GlcNAcylation. With YAP knockdown or YAP-T241 mutation, the increased sensitivity to ferroptosis induced by O-GlcNAcylation was abolished. In addition, the xenograft assay confirmed that O-GlcNAcylation increased ferroptosis sensitivity via TFRC in vivo. In summary, we are the first to find that O-GlcNAcylation can increase ferroptosis sensitivity in HCC cells via YAP/TFRC. Our work will provide a new basis for clinical therapeutic strategies for HCC patients. Nature Publishing Group UK 2021-04-16 /pmc/articles/PMC8052337/ /pubmed/33863873 http://dx.doi.org/10.1038/s41420-021-00468-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zhu, Guoqing Murshed, Abduh Li, Haojie Ma, Ji Zhen, Ni Ding, Miao Zhu, Jiabei Mao, Siwei Tang, Xiaochen Liu, Li Sun, Fenyong Jin, Lei Pan, Qiuhui O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title | O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title_full | O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title_fullStr | O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title_full_unstemmed | O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title_short | O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer |
title_sort | o-glcnacylation enhances sensitivity to rsl3-induced ferroptosis via the yap/tfrc pathway in liver cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052337/ https://www.ncbi.nlm.nih.gov/pubmed/33863873 http://dx.doi.org/10.1038/s41420-021-00468-2 |
work_keys_str_mv | AT zhuguoqing oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT murshedabduh oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT lihaojie oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT maji oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT zhenni oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT dingmiao oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT zhujiabei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT maosiwei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT tangxiaochen oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT liuli oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT sunfenyong oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT jinlei oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer AT panqiuhui oglcnacylationenhancessensitivitytorsl3inducedferroptosisviatheyaptfrcpathwayinlivercancer |